File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Daily associations between sleep and opioid use among adults with comorbid symptoms of insomnia and fibromyalgia

TitleDaily associations between sleep and opioid use among adults with comorbid symptoms of insomnia and fibromyalgia
Authors
Keywordssleep
opioid
insomnia
chronic pain
daily
Issue Date2021
PublisherThe American Academy of Sleep Medicine. The Journal's web site is located at http://www.aasmnet.org/jcsm
Citation
The Journal of Clinical Sleep Medicine, 2021, v. 17 n. 4, p. 729-737 How to Cite?
AbstractSTUDY OBJECTIVES:Disturbed sleep and use of opioid pain medication are common among individuals with chronic pain. Anecdotally, opioids are thought to promote sleep by relieving pain. This study aimed to determine whether opioid use is associated with daily sleep parameters (and vice versa) in adults with comorbid symptoms of insomnia and fibromyalgia. METHODS:Individuals reporting symptoms of insomnia and opioid use for fibromyalgia (n = 65, 93% women, 79% White) wore wrist actigraphy and completed daily diaries for 14 days (910 observations). Analyses examined daily associations between opioid dose (measured in lowest recommended dosage units) and three sleep parameters (actigraphy/self-reported total wake time and self-reported sleep quality). Multilevel models were used to account for the clustering of daily sleep and opioid assessments (level 1) within individuals (level 2). RESULTS:Opioid use did not have a significant daily effect on total wake time or sleep quality, and sleep parameters did not significantly impact opioid use the next day; however, participants reported worse sleep quality and greater doses of opioids on evenings that they experienced greater pain. CONCLUSIONS:Among adults reporting symptoms of insomnia and opioid use for fibromyalgia pain, opioid use is not reliably associated with wake time or sleep quality that night, and these sleep parameters are not significantly associated with opioid use the next day; however, evening pain has an adverse daily impact on both sleep quality and opioid use. Studies identifying strategies to prevent and manage fibromyalgia pain are needed, especially for individuals reporting comorbid insomnia and opioid use.
Persistent Identifierhttp://hdl.handle.net/10722/309079
ISSN
2023 Impact Factor: 3.5
2023 SCImago Journal Rankings: 1.039
PubMed Central ID

 

DC FieldValueLanguage
dc.contributor.authorMiller, MB-
dc.contributor.authorCurtis, AF-
dc.contributor.authorChan, WS-
dc.contributor.authorDeroche, CB-
dc.contributor.authorMcCrae, CS-
dc.date.accessioned2021-12-14T01:40:18Z-
dc.date.available2021-12-14T01:40:18Z-
dc.date.issued2021-
dc.identifier.citationThe Journal of Clinical Sleep Medicine, 2021, v. 17 n. 4, p. 729-737-
dc.identifier.issn1550-9389-
dc.identifier.urihttp://hdl.handle.net/10722/309079-
dc.description.abstractSTUDY OBJECTIVES:Disturbed sleep and use of opioid pain medication are common among individuals with chronic pain. Anecdotally, opioids are thought to promote sleep by relieving pain. This study aimed to determine whether opioid use is associated with daily sleep parameters (and vice versa) in adults with comorbid symptoms of insomnia and fibromyalgia. METHODS:Individuals reporting symptoms of insomnia and opioid use for fibromyalgia (n = 65, 93% women, 79% White) wore wrist actigraphy and completed daily diaries for 14 days (910 observations). Analyses examined daily associations between opioid dose (measured in lowest recommended dosage units) and three sleep parameters (actigraphy/self-reported total wake time and self-reported sleep quality). Multilevel models were used to account for the clustering of daily sleep and opioid assessments (level 1) within individuals (level 2). RESULTS:Opioid use did not have a significant daily effect on total wake time or sleep quality, and sleep parameters did not significantly impact opioid use the next day; however, participants reported worse sleep quality and greater doses of opioids on evenings that they experienced greater pain. CONCLUSIONS:Among adults reporting symptoms of insomnia and opioid use for fibromyalgia pain, opioid use is not reliably associated with wake time or sleep quality that night, and these sleep parameters are not significantly associated with opioid use the next day; however, evening pain has an adverse daily impact on both sleep quality and opioid use. Studies identifying strategies to prevent and manage fibromyalgia pain are needed, especially for individuals reporting comorbid insomnia and opioid use.-
dc.languageeng-
dc.publisherThe American Academy of Sleep Medicine. The Journal's web site is located at http://www.aasmnet.org/jcsm-
dc.relation.ispartofThe Journal of Clinical Sleep Medicine-
dc.rightsThis article has been accepted for publication in the Journal of Clinical Sleep Medicine published by the American Academy of Sleep Medicine -
dc.subjectsleep-
dc.subjectopioid-
dc.subjectinsomnia-
dc.subjectchronic pain-
dc.subjectdaily-
dc.titleDaily associations between sleep and opioid use among adults with comorbid symptoms of insomnia and fibromyalgia-
dc.typeArticle-
dc.identifier.emailChan, WS: chanwais@hku.hk-
dc.identifier.authorityChan, WS=rp02506-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.5664/jcsm.9002-
dc.identifier.pmid33226334-
dc.identifier.pmcidPMC8020701-
dc.identifier.scopuseid_2-s2.0-85103920076-
dc.identifier.hkuros330825-
dc.identifier.volume17-
dc.identifier.issue4-
dc.identifier.spage729-
dc.identifier.epage737-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats